Harish G. Ahuja

Hematology

1702 University Dr S
Fargo, ND 58103

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Reply to The effects of curative-intent cancer therapy on employment, work ability, and work limitations.

Reply to The effects of curative-intent cancer therapy on employment, work ability, and work limitations.

Journal: Cancer

Published: March 03, 2021

Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study.

Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study.

Journal: Cancer

Published: June 22, 2020

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.

Journal: Cancer

Published: February 01, 2015

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

Journal: Investigational new drugs

Published: April 13, 2013

Showing 1-4 of 4

Last Updated: 09/26/2026